Doktorgradsavhandling

• Amani Thomas Mori; Bjarne Robberstad (2015). Pharmacoeconomics and Formulary Decision-Making in Tanzania. Generating Evidence for Antimalarial Drugs. (ekstern lenke)

Forelesning

• Reidun Lisbet Skeide Kjome; Lone Holst; Svein Haavik et al. (2019). Farmasøyter med og uten genser: Hvordan farmasiutdanningene i Bergen og Dar es Salaam blir bedre av et nord-sør samarbeid. (ekstern lenke)

Fremhevet artikkel i media

• Elizabeth Peacocke; Elina Dale; Amani Thomas Mori et al. (2024). Measuring the value of the WHO Model list of essential medicines. (ekstern lenke)

Konferanseforedrag

• Amani Thomas Mori; Lucy C Okell; Titus Kimutai Kwambai et al. (2021). Epidemiological impact of PMC. (ekstern lenke)
• Amani Thomas Mori (2018). Post-discharge Malaria Chemoprevention for Children Under the Age of 5 years in Africa. (ekstern lenke)
• Titus Kimutai Kwambai; Amani Thomas Mori; Sarah Nevitt et al. (2018). Post-discharge risks of morbidity and mortality in children in malaria endemic settings in Africa: A systematic review and meta-analysis - Oral presentation. (ekstern lenke)

Vitenskapelig artikkel

• Jackson M. Bwimba; Alphoncina Kagaigai; Elizabeth Gudu et al. (2026). Cost analysis of implementing community-based mass drug administration for schistosomiasis control among adult individuals using community drug distributors in Ukerewe district council, North-Western Tanzania. (ekstern lenke)
• Gibson B. Kagaruki; Peter Mathias Karoli; Willfredius M. Rutahoile et al. (2025). Assessment of community knowledge on non-communicable diseases to inform the pilot of WHO PEN-Plus initiatives in selected two districts in Tanzania. (ekstern lenke)
• Emmanuel Kimaro; Joseph John; Prisca Damiano et al. (2025). Impact of insulin storage and syringe reuse on insulin sterility in diabetes mellitus patients in Mwanza Tanzania. (ekstern lenke)
• Aneth H. Muchunguzi; Emmanuel Kimaro; Eveline T. Konje et al. (2024). Factors associated with glycaemic control and diabetes complications in patients at Bugando Medical Centre, Mwanza, Tanzania: A cross-sectional study design. (ekstern lenke)
• Amani Thomas Mori; Mweetwa Mudenda; Bjarne Robberstad et al. (2024). Impact of cash transfer programs on healthcare utilization and catastrophic health expenditures in rural Zambia: a cluster randomized controlled trial. (ekstern lenke)
• Ingvild Fossgard Sandøy; Mweetwa Mudenda; Hanne Keyser Hegdahl et al. (2024). Effectiveness of economic support, comprehensive sexuality education and community dialogue on early childbearing and sitting for grade nine exams among adolescent girls in rural Zambia: a cluster randomised trial. (ekstern lenke)
• Peter Karoli; Mary Mayige; Gibson Kagaruki et al. (2024). Mid-level healthcare workers knowledge on non-communicable diseases in Tanzania: a district-level pre-and post-training assessment. (ekstern lenke)
• Amisa Tindamanyile Chamani; Bjarne Robberstad; Amani Thomas Mori (2024). Budget Impact Analysis of Implementing Antenatal Care Recommendations for Positive Pregnancy Outcomes at Public Primary Facilities in Tanzania. (ekstern lenke)
• Harrieth Peter Ndumwa; Amani Thomas Mori; Georg Mugambage Ruhago et al. (2024). Cost analysis for initiating an integrated package of essential non-communicable disease interventions (PEN-Plus) in Kondoa District Hospital, Tanzania: a time-driven activity-based costing (TDABC) study protocol. (ekstern lenke)
• Alphoncina Kagaigai; Amani Thomas Mori; Amani Anaeli et al. (2023). Whether or not to enroll, and stay enrolled? A Tanzanian cross-sectional study on voluntary health insurance. (ekstern lenke)
• Alphoncina Kagaigai; Amani Anaeli; Sverre Ole Grepperud et al. (2023). Healthcare utilization and catastrophic health expenditure in rural Tanzania: does voluntary health insurance matter?. (ekstern lenke)
• Lucy C. Okell; Titus K. Kwambai; Aggrey Dhabangi et al. (2023). Projected health impact of post-discharge malaria chemoprevention among children with severe malarial anaemia in Africa. (ekstern lenke)
• Amani Thomas Mori; Cecilia J. Nyabakari (2023). Cost of image-guided percutaneous nephrostomy among cervical cancer patients at Muhimbili National Hospital in Tanzania. (ekstern lenke)
• Amani Thomas Mori (2023). Mandatory health insurance for the informal sector in Tanzania—has it worked anywhere!. (ekstern lenke)
• Peter Winskill; Aggrey Dhabangi; Titus K. Kwambai et al. (2023). Estimating the burden of severe malarial anaemia and access to hospital care in East Africa. (ekstern lenke)
• Titus K Kwambai; Amani Thomas Mori; Sarah Nevitt et al. (2022). Post-discharge morbidity and mortality in children admitted with severe anaemia and other health conditions in malaria-endemic settings in Africa: a systematic review and meta-analysis. (ekstern lenke)
• Amani Thomas Mori; Ngwegwe Bulula; Richard Magodi et al. (2022). Domestic funding opportunities for Tanzania as five new Middle-Income countries brace for reduced Gavi support for immunization. (ekstern lenke)
• Gavin Surgey; Amani Thomas Mori; Rob Baltussen (2022). Health Technology Assessment in Tanzania: Capacity and experience of HTA committee members. (ekstern lenke)
• Melf-Jakob Kühl; Thandile Gondwe; Aggrey Dhabangi et al. (2022). Economic evaluation of postdischarge malaria chemoprevention in preschool children treated for severe anaemia in Malawi, Kenya, and Uganda: A cost-effectiveness analysis. (ekstern lenke)
• Amisa Tindamanyile Chamani; Amani Thomas Mori; Bjarne Robberstad (2021). Implementing standard antenatal care interventions: health system cost at primary health facilities in Tanzania. (ekstern lenke)
• Alphoncina Kagaigai; Amani Anaeli; Amani Thomas Mori et al. (2021). Do household perceptions influence enrolment decisions into community-based health insurance schemes in Tanzania?. (ekstern lenke)
• Amani Thomas Mori; Penina Mnandi; Godeliver Kagashe et al. (2021). ABC-VEN Analysis of Medicine Expenditure at Mwananyamala Regional Hospital in Tanzania. (ekstern lenke)
• Peter Binyaruka; Amani Thomas Mori (2021). Economic consequences of caesarean section delivery: evidence from a household survey in Tanzania. (ekstern lenke)
• Rashid Bakari Kirua; Mary Justin Temu; Amani Thomas Mori (2020). Prices of medicines for the management of pain, diabetes and cardiovascular diseases in private pharmacies and the national health insurance in Tanzania. (ekstern lenke)
• Bulula Ngwegwe; Mwiru Diana; Omary Swalehe et al. (2020). Vaccine storage and distribution between expanded program on immunization and medical store department in Tanzania: a cost-minimization analysis. (ekstern lenke)
• Hamidad Farid Hussain; Amani Thomas Mori; Aamir Javed Khan et al. (2019). The cost-effectiveness of incentive-based active case finding for tuberculosis (TB) control in the private sector Karachi, Pakistan. (ekstern lenke)
• Amani Thomas Mori; Linda Milimo Kampata; Patrick Musonda et al. (2017). Cost-benefit and extended cost-effectiveness analysis of a comprehensive adolescent pregnancy prevention program in Zambia: study protocol for a cluster randomized controlled trial. (ekstern lenke)
• Frida Namnyak Ngalesoni; Georg Mugambage Ruhago; Amani Thomas Mori et al. (2016). Equity impact analysis of medical approaches to cardiovascular diseases prevention in Tanzania. (ekstern lenke)
• Amani Thomas Mori; Ole Frithjof Norheim; Bjarne Robberstad (2016). Budget impact analysis of using dihydroartemisinin–piperaquine to treat uncomplicated malaria in children in Tanzania. (ekstern lenke)
• Frida Namnyak Ngalesoni; Georg Mugambage Ruhago; Amani Thomas Mori et al. (2016). Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: A Markov modelling study. (ekstern lenke)
• Amani Thomas Mori; Frida Namnyak Ngalesoni; Ole Frithjof Norheim et al. (2014). Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania. (ekstern lenke)
• Amani Thomas Mori; Eliangiringa Amos Kaale; Frida Ngalesoni et al. (2014). The role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of Tanzania. (ekstern lenke)
• Amani Thomas Mori; Eliangiringa Amos Kaale; Peter Risha (2013). Reforms: a quest for efficiency or an opportunity for vested interests'? a case study of pharmaceutical policy reforms in Tanzania. (ekstern lenke)
• Amani Thomas Mori; Paul Gavaza; Bjarne Robberstad (2013). Role of pharmacoeconomics in developing countries. (ekstern lenke)
• Amani Thomas Mori; Eliangiringa A. Kaale (2012). Priority setting for the implementation of artemisinin-based combination therapy policy in Tanzania: evaluation against the accountability for reasonableness framework. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Amani Thomas Mori; Grace John Mallange; Melf-Jakob Kühl et al. (2024). Cost of treating severe malaria in children in Africa: a systematic literature review. (ekstern lenke)
• Amani Thomas Mori; Peter Binyaruka; Peter Hangoma et al. (2020). Patient and health system costs of managing pregnancy and birth-related complications in sub-Saharan Africa: A systematic review. (ekstern lenke)
• Amani Thomas Mori; Estella Meena; Eliangiringa Amos Kaale (2018). Economic cost of substandard and falsified human medicines and cosmetics with banned ingredients in Tanzania from 2005 to 2015: A retrospective review of data from the regulatory authority. (ekstern lenke)
• Amani Thomas Mori; Bjarne Robberstad (2012). Pharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review. (ekstern lenke)

Se en fullstendig oversikt over publikasjoner i NVA.